Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.
[contact-form-7 404 "Not Found"]

ePatientFinder Blog

Wake Up!

On 08 December 2016, it was published that in the first time in more than two decades, the life expectancy for Americans is on the decline despite having advanced treatments to help prolong lives.  More disturbing, the major reasons for this projection is due to...

Read More

Biogen Licenses Phase 2 Anti-Tau Antibody from Bristol-Myers Squibb

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ:BIIB) today announced an agreement to exclusively license BMS-986168, a Phase 2-ready experimental medicine with potential in Alzheimer’s disease (AD) and progressive supranuclear palsy (PSP), from Bristol-Myers Squibb (NYSE:BMY). BMS-986168 is an antibody targeting extracellular tau, the protein that forms the...

Read More